Lenalidomide is active for extramedullary disease in refractory multiple myeloma

被引：14
|
作者：
Nakazato, Tomonori [1 ]
Mihara, Ai [1 ]
Ito, Chisako [1 ]
Sanada, Yukinari [1 ]
Aisa, Yoshinobu [1 ]
机构：
[1] Yokohama Municipal Citizens Hosp, Dept Hematol, Hodogaya Ku, Yokohama, Kanagawa 2408555, Japan
来源：
ANNALS OF HEMATOLOGY | 2012年 / 91卷 / 03期
关键词：
THALIDOMIDE; BORTEZOMIB;
D O I：
10.1007/s00277-011-1272-6
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：473 / 474
页数：2
相关论文
共 50 条
  • [21] Safety and Efficacy of Lenalidomide in Relapsed or Refractory Multiple Myeloma
    Alegre, Adrian
    Vicuna, Isabel
    Aguado, Beatriz
    CLINICAL MEDICINE INSIGHTS-ONCOLOGY, 2012, 6
  • [22] Lenalidomide plus Dexamethasone for Relapsed or Refractory Multiple Myeloma
    Dabkara, Deepak
    Bajpai, Jyoti
    INDIAN JOURNAL OF MEDICAL AND PAEDIATRIC ONCOLOGY, 2008, 29 (03) : 10 - 13
  • [23] Imaging Features of Extramedullary, Relapsed, and Refractory Multiple Myeloma involving the Liver Across Treatment With Cyclophosphamide, Lenalidomide, Bortezomib, and Dexamethasone
    Saboo, Sachin S.
    Fennessy, Fiona
    Benajiba, Lina
    Laubach, Jacob
    Anderson, Kenneth C.
    Richardson, Paul G.
    JOURNAL OF CLINICAL ONCOLOGY, 2012, 30 (20) : E175 - E179
  • [24] Carfilzomib-Lenalidomide-Dexamethasone in the Management of Lenalidomide-Refractory Multiple Myeloma
    Cerchione, Claudio
    Catalano, Lucio
    Nappi, Davide
    Pareto, Anna Emanuele
    Musuraca, Gerardo
    Lucchesi, Alessandro
    Pane, Fabrizio
    Martinelli, Giovanni
    CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2020, 20 : S310 - S310
  • [25] Carfilzomib-Lenalidomide-Dexamethasone in the Management of Lenalidomide-Refractory Multiple Myeloma
    Cerchione, Claudio
    Martinelli, Giovanni
    Catalano, Lucio
    AMERICAN JOURNAL OF HEMATOLOGY, 2020, 95 : S5 - S6
  • [26] Carfilzomib-Lenalidomide-Dexamethasone in the Management of Lenalidomide-Refractory Multiple Myeloma
    Cerchione, Claudio
    Martinelli, Giovanni
    Nappi, Davide
    Pareto, Anna Emanuele
    Di Perna, Maria
    Ronconi, Sonia
    Pane, Fabrizio
    Catalano, Lucio
    CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2019, 19 (10): : E358 - E359
  • [27] Carfilzomib-Lenalidomide-Dexamethasone in the Management of Lenalidomide-Refractory Multiple Myeloma
    Cerchione, Claudio
    Ferrara, Katia
    Peluso, Ilaria
    Di Perna, Maria
    Nappi, Davide
    Pareto, Anna Emanuele
    Pane, Fabrizio
    Catalano, Lucio
    CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2018, 18 : S255 - S255
  • [28] CARFILZOMIB-LENALIDOMIDE-DEXAMETHASONE IN THE MANAGEMENT OF LENALIDOMIDE-REFRACTORY MULTIPLE MYELOMA
    Cerchione, C.
    Catalano, L.
    Nappi, D.
    Musuraca, G.
    Lucchesi, A.
    Pareto, A. E.
    Di Perna, M.
    Ferrara, K.
    Ronconi, S.
    Ceccolini, M.
    Cangini, D.
    Giannini, M. B.
    Di Battista, V.
    Simonetti, G.
    Ferrari, A.
    Bochicchio, M. T.
    di Rora, A. Ghelli Luserna
    Ghetti, M.
    Napolitano, R.
    Fontana, M. C.
    Padella, A.
    Pane, F.
    Martinelli, G.
    HAEMATOLOGICA, 2020, 105 : S104 - S104
  • [29] Carfilzomib-Lenalidomide-Dexamethasone in the Management of Lenalidomide-Refractory Multiple Myeloma
    Cerchione, Claudio
    Nappi, Davide
    Pareto, Anna Emanuele
    Pane, Fabrizio
    Catalano, Lucio
    Martinelli, Giovanni
    BLOOD, 2021, 138
  • [30] CARFILZOMIB-LENALIDOMIDE-DEXAMETHASONE IN THE MANAGEMENT OF LENALIDOMIDE-REFRACTORY MULTIPLE MYELOMA
    Cerchione, C.
    Ferrara, K.
    Peluso, I.
    Di Perna, M.
    Zacheo, I.
    Nappi, D.
    Pareto, A. E.
    Pane, F.
    Catalano, L.
    HAEMATOLOGICA, 2018, 103 : S85 - S85
12345